ARTICANZ - Beta (ver 0.9)
Annotated Registry of Trials in Cancer, Australia and New Zealand Ed.
- Results - catype/medical-oncology/salivary-gland/advanced
Home
By cancer type
By drug class
By site
Data
FAQ
About
⚠
ARTICANZ provides informational content about cancer drug trials in Australia/NZ that is updated weekly but may not be completely accurate, and should not replace medical advice from qualified healthcare professionals. The platform is intended to be useful, providing information "as is" without warranties. Non-medical users must always consult healthcare providers for all clinical decisions.
Search results
Head & neck and Neurological / Salivary gland - Advanced
2
trial(s) found.
NCT04140526
Advanced
Phase 1 / Phase 2
Recruiting
Safety, Pharmacokinetics (PK), and Efficacy of ONC-392 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumors and NSCLC: An Open Label Phase IA/IB Study. Preserve CTLA4 Checkpoint Function (
PRESERVE-001
)
anti-CTLA-4 monoclonal antibody
anti-PD-1 monoclonal antibody
Adenoid cystic carcinoma
Breast cancer
Cervical cancer
Clear cell renal cell carcinoma
Colorectal cancer
Gastric cancer
Gastroesophageal junction adenocarcinoma
Head and neck cancer
Melanoma
Non-small cell lung cancer
Oesophageal cancer
Ovarian cancer
Pancreatic cancer
Prostate cancer
Salivary gland cancer
Sarcoma
Small-cell lung cancer
Solid tumour
Urothelial carcinoma
NSW
2305 - New Lambton Heights - Newcastle Private Hospital
QLD
4215 - Southport - Tasman Oncology
SA
5000 - Adelaide - Royal Adelaide Hospital - Adelaide Cancer Centre
5042 - Bedford Park - Southern Oncology Clinical Research Unit
NCT02628067
Advanced
Phase 2
Recruiting
A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158) (
KEYNOTE-158
)
anti-PD-1 monoclonal antibody
Anal cancer
Biliary tract cancer
Cancer
Cervical cancer
Cholangiocarcinoma
Colorectal cancer
Endometrial cancer
Endometrial carcinoma
Lung carcinoid tumour
Mesothelioma
Neuroendocrine tumour
Pancreatic neuroendocrine tumour
Salivary gland cancer
Salivary gland carcinoma
Small-cell lung cancer
Solid tumour
Thyroid cancer
Vulval cancer
Additional search terms:
API and Webpage URLs:
Copy /Bookmark
Filters
Recruitment Status
Recruiting (2)
Recruitment Country and State
NSW (1)
QLD (1)
SA (1)
Phase
Phase 1 / Phase 2 (1)
Phase 2 (1)
Trial Type
Advanced (2)
Cancer Therapy Class
PD-1
100%
PD-1/PD-L1
100%
CTLA4
50%
Facility
2305 - New Lambton Heights - Newcastle Private Hospital (1)
4215 - Southport - Tasman Oncology (1)
5000 - Adelaide - Royal Adelaide Hospital - Adelaide Cancer Centre (1)
5042 - Bedford Park - Southern Oncology Clinical Research Unit (1)
Cancer Type
Cancer
Carcinoma
Cervical cancer
Colorectal cancer
Gastrointestinal cancer
Gynaecological cancer
HPV-related cancer
HPV16-positive cancer
Head and neck cancer
Lower gastrointestinal cancer
Lung cancer
Neuroendocrine carcinoma
Pancreatic cancer
Pancreatobiliary cancer
Respiratory tract cancer
Salivary gland cancer
Small-cell lung cancer
Small-cell neuroendocrine carcinoma
Solid tumour
Thoracic cancer
Upper gastrointestinal cancer
Viral-related cancer
Adenoid cystic carcinoma
Breast cancer
Cancer Solid tumour Carcinoma
Clear cell renal cell carcinoma
Gastric cancer
Gastric carcinoma
Gastroesophageal cancer
Gastroesophageal junction adenocarcinoma
Kidney cancer
Male genital cancers
Melanoma
Non-small cell lung cancer
Oesophageal cancer
Ovarian cancer
Prostate cancer
Sarcoma
Urogenital cancer
Urothelial carcinoma
Anal cancer
Biliary tract cancer
Cholangiocarcinoma
Endocrine gland cancer
Endometrial cancer
Endometrial carcinoma
Gastro-entero-pancreatic neuroendocrine tumour
Hepatobiliary cancer
Lung carcinoid tumour
Mesothelioma
Neuroendocrine tumour
Pancreatic neuroendocrine tumour
Salivary gland carcinoma
Thyroid cancer
Vaginal and vulvar cancer
Vulval cancer
URLs for this search
API URL:
Copy
Bookmarkable URL:
Copy